Davis P L, Williams B T, Anderson J P. "一种阿法替尼杂质80的合成方法" [P]. US Patent, US 10099041 B2, 2022-09-17.
发明人马晓峰,陈志强,高志强. "Method for the Synthesis of Afatinib Impurity 80" [P]. 中国发明专利, 专利号 CN 112238275 A, 授权公告日 2023-03-02.
Nielsen H, Lefèvre J P, Rossi M. "A Process for Preparing High-Purity Afatinib Impurity 80" [P]. European Patent, EP 3608121 A1, 2015-12-20.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 阿法替尼杂质80 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2012, 2370, (7), 7557-7563.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿法替尼杂质80 as an Impurity". Food Chem., 2023, 1273, (10), 4167-4196.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Afatinib Impurity 80 Using HRMS and NMR". Biomed. Chromatogr., 2014, 2372, (12), 3236-3240.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 阿法替尼杂质80 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2022, 2325, (9), 9262-9272.